Sensipar
Generic name: Cinacalcet
Drug class:
Calcimimetics
Usage of Sensipar
Sensipar decreases levels of parathyroid hormone (PTH), calcium, and phosphorous in the body.
Sensipar is used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.
Sensipar is also used to treat hypercalcemia (high levels of calcium in the blood) in people with cancer of the parathyroid gland, and in people with overactive parathyroid glands that cannot be treated surgically.
Sensipar side effects
Get emergency medical help if you have signs of an allergic reaction to Sensipar : hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Sensipar side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Sensipar
You should not use Sensipar if you are allergic to cinaCalcet, or if you have:
To make sure Sensipar is safe for you, tell your doctor if you have ever had:
It is not known whether Sensipar will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It is not known whether cinacalcet passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are taking this medicine.
Sensipar is not FDA-approved for use by anyone younger than 18 years old.
Relate drugs
How to use Sensipar
Usual Adult Dose for Secondary Hyperparathyroidism:
Initial dose: 30 mg orally once a day (cinacalcet should be titrated no more frequently than every 2 to 4 weeks through sequential doses of 30, 60, 90, 120, and 180 mg orally once daily). Maintenance dose: 30 to 180 mg orally once a day Maximum dose: 180 mg once a day Approved indication: Secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
Usual Adult Dose for Hypercalcemia of Malignancy:
Initial dose: 30 mg orally twice a day (Titrate dose every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg 3 or 4 times daily). Maintenance dose: 60 mg to 360 mg orally per day Maximum dose: 90 mg four times a day Approved indication: Parathyroid carcinoma and primary hyperparathyroidism who are unable to undergo parathyroidectomy
Usual Adult Dose for Primary Hyperparathyroidism:
Initial dose: 30 mg orally twice a day (Titrate dose every 2 to 4 weeks through sequential doses of 30 mg twice daily, 60 mg twice daily, 90 mg twice daily, and 90 mg 3 or 4 times daily). Maintenance dose: 60 mg to 360 mg orally per day Maximum dose: 90 mg four times a day Approved indication: Parathyroid carcinoma and primary hyperparathyroidism who are unable to undergo parathyroidectomy
Warnings
You should not take Sensipar if you have low levels of calcium in your blood (hypocalcemia).
Before you take Sensipar, tell your doctor if you have high blood pressure, heart disease, heart failure, a heart rhythm disorder, liver disease, or a history of seizures.
Sensipar works best if you take it with food or shortly after eating a meal. Do not crush or break a tablet. Swallow the pill whole.
Call your doctor at once if you have a serious side effect such as numbness or tingly feeling around your mouth, fast or slow heart rate, muscle tightness or contraction, overactive reflexes, seizure, feeling short of breath, swelling, rapid weight gain, or feeling like you might pass out.
To be sure Sensipar is helping your condition, your blood may need to be tested often. Visit your doctor regularly.
What other drugs will affect Sensipar
Many drugs can interact with cinacalcet. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all medicines you use, and those you start or stop using during your treatment with Sensipar. Give a list of all your medicines to any healthcare provider who treats you.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions